Replacing chemotherapy with blinatumomab improved event-free survival and reduced toxicity in high-risk pediatric ALL, data show.
Martin Schrappe, MD, PhD
Advertisement
Martin Schrappe, MD, PhD, is affiliated with the University Hospital Schleswig-Holstein.
Articles by Martin Schrappe, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 FAQs: Ebola Outbreaks and the Challenge of Public Trust
2
How Hospital Specialty Pharmacies Are Closing the Pharmacy Desert Gap
3
Targeting Oxidative Stress Could Fill a Gap in the Vitiligo Treatment Toolbox
4
Incretin Innovation, Metabolic Liver Disease, and Cardiovascular Risk Reduction Dominate ADA 2026
5